Section IV λ CNS Pharmacology
λAnesthesia protocols include several agents in combinations.
λInhaled anesthetics have varying potency in proportion to their lipid solubility.
λA MAC (minimal alveolar anesthetic concentration) is defined as the concentration of inhaled anesthetic, as a % of inspired air, at which 50% of patients do not respond to a surgical stimulus.
−MAC is a measure of potency: ED50.
−The more lipid soluble the anesthetic, the lower the MAC and the greater the potency.
−MAC values are additive.
−MAC values are lower in the elderly and in the presence of opiates or sedative-hypnotics.
λRates of onset and recovery depend on the blood–gas ratio:
−The more soluble the anesthetic in the blood, the slower the anesthesia.
−Anesthetics with high blood–gas ratios are associated with slow onset.
−Anesthetics with high blood–gas ratios are associated with slow recovery.
−Anesthetics with low blood–gas ratios have fast onset and recovery.
Intravenous Anesthetics
λMidazolam
−Benzodiazepine used for:
ºPreoperative sedation
ºAnterograde amnesia
ºInduction
ºOutpatient surgery
−Depresses respiratory function
λPropofol
−Used for induction and maintenance of anesthesia
−Antiemetic
−CNS and cardiac depressant
λFentanyl
−Opiate used for induction and maintenance of anesthesia
−Depresses respiratory function
−See Opioid Analgesics, chapter 7 in this section
λKetamine
−Dissociative anesthetic
– NMDA-receptor antagonist
−Induction of anesthesia
−Emergent delirium, hallucinations
−Cardiovascular stimulation
−↑ intracranial pressure
154
Section IV λ CNS Pharmacology
SKELETAL MUSCLE RELAXANTS
α
δ Na/K β
γ α
Figure IV-6-3. Nicotinic ACh Receptor
of the Neuromuscular Junction
λNicotinic receptors have five subunits.
λTwo ACh bind each to two α subunits in order to open the Na+ channel.
λThis depolarizes the muscle.
λUsed mainly in anesthesia protocols or in the ICU to afford muscle relaxation and/or immobility.
λMuscle relaxants interact with nicotinic ACh receptors at the neuromuscular junction.
λDrugs:
−Nondepolarizing (competitive)
ºNicotinic antagonists
ºd-Tubocurarine prototype
ºReversible with AChE inhibitors
ºProgressive paralysis (face, limbs, respiratory muscle)
ºNo effects on cardiac and smooth muscle
ºNo CNS effects
ºSpecific drugs:
Atracurium
* Rapid recovery
* Safe in hepatic or renal impairment
* Spontaneous inactivation to laudanosine * Laudanosine can cause seizures
−Depolarizing (noncompetitive)
ºNicotinic agonist
ºSpecific drug: succinylcholine
ºTwo phases:
Phase I: depolarization, fasciculation, prolong depolarization, flaccid paralysis
Phase II: desensitization
ºAChE inhibitors ↑ phase I; may reverse phase II
ºRapidly hydrolyzed by pseudocholinesterase: short duration
156